CURA_1170x120_8-22-19

Auvi-Q

Kaleo to launch Auvi-Q auto-injector for young children

Kaleo to launch Auvi-Q auto-injector for young children

RICHMOND, Va. — Next year, Kaleo plans to release Auvi-Q 0.1 mg, a version of its epinephrine auto-injector for infants and small children. Kaleo said Monday that the Food and Drug Administration has approved its supplemental New Drug Application (sNDA) for Auvi-Q 0.1 mg, which can be used to treat life-threatening allergic reactions, including anaphylaxis,

CVS serves up low-cost EpiPen option

CVS serves up low-cost EpiPen option

WOONSOCKET, R.I. — In the wake of the public outcry over pricing for Mylan’s EpiPen epinephrine auto-injector for anaphylaxis, CVS Health announced that it’s providing a low-cost alternative. CVS said Thursday that Impax Laboratories’ authorized generic for the Adrenaclick epinephrine auto-injector is now available at all CVS Pharmacy drug stores at a cash price of $109.99

Kaleo set to bring back Auvi-Q epinephrine injector

Kaleo set to bring back Auvi-Q epinephrine injector

RICHMOND, Va. — Pharmaceutical company Kaleo plans to reintroduce the Auvi-Q epinephrine auto-injector to the U.S. market in the first half of 2017. For emergency use in treating life-threatening allergic reactions such as anaphylaxis, Auvi-Q is expected to provide an option to the EpiPen from Mylan Inc., which has been lambasted by government officials, the